223 related articles for article (PubMed ID: 30888638)
21. Proliferative verrucous leukoplakia: an elusive disorder.
Parashar P
J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
[TBL] [Abstract][Full Text] [Related]
22. Proliferative verrucous leukoplakia and its progression to oral carcinoma: report of three cases.
Morton TH; Cabay RJ; Epstein JB
J Oral Pathol Med; 2007 May; 36(5):315-8. PubMed ID: 17448142
[TBL] [Abstract][Full Text] [Related]
23. Aggressive, multifocal oral verrucous leukoplakia: proliferative verrucous leukoplakia or not?
Ghazali N; Bakri MM; Zain RB
J Oral Pathol Med; 2003 Aug; 32(7):383-92. PubMed ID: 12846784
[TBL] [Abstract][Full Text] [Related]
24. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
Adv Anat Pathol; 2013 Nov; 20(6):416-23. PubMed ID: 24113312
[TBL] [Abstract][Full Text] [Related]
25. Proliferative verrucous leukoplakia, squamous cell carcinoma and axillary metastasis.
Gouvêa AF; Moreira AE; Reis RR; de Almeida OP; Lopes MA
Med Oral Patol Oral Cir Bucal; 2010 Sep; 15(5):e704-8. PubMed ID: 20173705
[TBL] [Abstract][Full Text] [Related]
26. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia.
Fernandes D; Barbeiro CO; Palaçon MP; Biancardi MR; Ferrisse TM; Silveira HA; Castilho RM; de Almeida LY; Leon JE; Bufalino A
Immunology; 2023 Jan; 168(1):96-109. PubMed ID: 36056642
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
28. Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features.
Herreros-Pomares A; Hervás D; Bagan-Debon L; Proaño A; Garcia D; Sandoval J; Bagan J
Oral Dis; 2024 Apr; 30(3):1072-1083. PubMed ID: 36892444
[TBL] [Abstract][Full Text] [Related]
29. Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
Rintala M; Vahlberg T; Salo T; Rautava J
Head Neck; 2019 May; 41(5):1499-1507. PubMed ID: 30536498
[TBL] [Abstract][Full Text] [Related]
30. [Proliferative verrucous leukoplakia: Three cases and literature review].
Ottavioli A; Campana F; Catherine JH; Massereau E; Del Grande J; Ordioni U
Ann Dermatol Venereol; 2016 Mar; 143(3):187-96. PubMed ID: 26832120
[TBL] [Abstract][Full Text] [Related]
31. Proliferative verrucous leukoplakia: a case report.
Lopes MA; Pazoki AE; Ord RA
Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
[TBL] [Abstract][Full Text] [Related]
32. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature.
Cabay RJ; Morton TH; Epstein JB
J Oral Pathol Med; 2007 May; 36(5):255-61. PubMed ID: 17448134
[TBL] [Abstract][Full Text] [Related]
33. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
[TBL] [Abstract][Full Text] [Related]
34. Wolf in sheep's clothing - Oral proliferative verrucous leukoplakia: Progression with longitudinal molecular insights.
Afkhami M; Maghami E; Gernon TJ; Villaflor V; Bell D
Ann Diagn Pathol; 2023 Apr; 63():152104. PubMed ID: 36640643
[TBL] [Abstract][Full Text] [Related]
35. Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
Borgna SC; Clarke PT; Schache AG; Lowe D; Ho MW; McCarthy CE; Adair S; Field EA; Field JK; Holt D; Risk JM; Rajlawat BP; Triantafyllou A; Shaw RJ
Head Neck; 2017 Oct; 39(10):1997-2003. PubMed ID: 28640498
[TBL] [Abstract][Full Text] [Related]
36. Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma--a clinical, histologic and immunohistochemical study.
Akrish S; Ben-Izhak O; Sabo E; Rachmiel A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Mar; 119(3):318-25. PubMed ID: 25547823
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of survivin expression in leukoplakia, lichen planus, and oral squamous cell carcinoma: An immunohistochemical study.
Angelin D; Nair BJ
J Cancer Res Ther; 2020; 16(3):569-574. PubMed ID: 32719269
[TBL] [Abstract][Full Text] [Related]
38. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia.
Farah CS; Shearston K; Melton PE; Fox SA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jul; 138(1):99-111. PubMed ID: 38760284
[TBL] [Abstract][Full Text] [Related]
40. Lichenoid areas may arise in early stages of proliferative verrucous leukoplakia: A long-term study of 34 patients.
Barba-Montero C; Lorenzo-Pouso AI; Gándara-Vila P; Blanco-Carrión A; Marichalar-Mendía X; García-García A; Pérez-Sayáns M
J Oral Pathol Med; 2022 Jul; 51(6):573-581. PubMed ID: 35596256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
